Trial Profile

Aezea (Cenersen) in Combination With Chemotherapy for the Treatment of Acute Myelogenous Leukemia Subjects = 55 Years of Age With No Response to a Single Frontline Induction Course in a Randomized Double-Blind Placebo-Controlled Multi-Center Study.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

21 Jul 2012 Additional location (United Kingdom) added as reported by European Clinical Trials Database.
21 Jul 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2008-002160-34).
13 Oct 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com